2018-2023 Global Gastrointestinal Drugs Consumption Market Report

August 2018 | 159 pages | ID: 265DB22B639EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Gastrointestinal Drugs market for 2018-2023.

Gastrointestinal (GI) disorders include functional bowel diseases such as irritable bowel syndrome (IBS) and inflammatory bowel diseases such as Crohn's disease (CD) and colitis. Some gastrointestinal drug can control or moderate the symptoms of gastrointestinal disorders.
Over the next five years, LPI(LP Information) projects that Gastrointestinal Drugs will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.

This report presents a comprehensive overview, market shares, and growth opportunities of Gastrointestinal Drugs market by product type, application, key manufacturers and key regions.

To calculate the market size, LP Information considers value and volume generated from the sales of the following segments:

Segmentation by product type:

• Prescription Gastrointestinal Drug
• OTC Gastrointestinal Drug

Segmentation by application:

• Chronic Gastritis
• Functional Dyspepsia
• Peptic Ulcer
• Acute Gastroenteritis
• Other

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Spain
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report:

• AstraZeneca
• Sanofi
• Bayer
• Pfizer
• GlaxoSmithKline
• Teva
• Zeria(Tillotts)
• Perrigo
• Boehringer Ingelheim
• Purdue Pharma
• C.B. Fleet
• Abbott
• Jiangzhong
• Xian-Janssen

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

• To study and analyze the global Gastrointestinal Drugs consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
• To understand the structure of Gastrointestinal Drugs market by identifying its various subsegments.
• Focuses on the key global Gastrointestinal Drugs manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
• To analyze the Gastrointestinal Drugs with respect to individual growth trends, future prospects, and their contribution to the total market.
• To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
• To project the consumption of Gastrointestinal Drugs submarkets, with respect to key regions (along with their respective key countries).
• To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
• To strategically profile the key players and comprehensively analyze their growth strategies.

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Gastrointestinal Drugs Consumption 2013-2023
  2.1.2 Gastrointestinal Drugs Consumption CAGR by Region
2.2 Gastrointestinal Drugs Segment by Type
  2.2.1 Prescription Gastrointestinal Drug
  2.2.2 OTC Gastrointestinal Drug
2.3 Gastrointestinal Drugs Consumption by Type
  2.3.1 Global Gastrointestinal Drugs Consumption Market Share by Type (2013-2018)
  2.3.2 Global Gastrointestinal Drugs Revenue and Market Share by Type (2013-2018)
  2.3.3 Global Gastrointestinal Drugs Sale Price by Type (2013-2018)
2.4 Gastrointestinal Drugs Segment by Application
  2.4.1 Chronic Gastritis
  2.4.2 Functional Dyspepsia
  2.4.3 Peptic Ulcer
  2.4.4 Acute Gastroenteritis
  2.4.5 Other
2.5 Gastrointestinal Drugs Consumption by Application
  2.5.1 Global Gastrointestinal Drugs Consumption Market Share by Application (2013-2018)
  2.5.2 Global Gastrointestinal Drugs Value and Market Share by Application (2013-2018)
  2.5.3 Global Gastrointestinal Drugs Sale Price by Application (2013-2018)

3 GLOBAL GASTROINTESTINAL DRUGS BY PLAYERS

3.1 Global Gastrointestinal Drugs Sales Market Share by Players
  3.1.1 Global Gastrointestinal Drugs Sales by Players (2016-2018)
  3.1.2 Global Gastrointestinal Drugs Sales Market Share by Players (2016-2018)
3.2 Global Gastrointestinal Drugs Revenue Market Share by Players
  3.2.1 Global Gastrointestinal Drugs Revenue by Players (2016-2018)
  3.2.2 Global Gastrointestinal Drugs Revenue Market Share by Players (2016-2018)
3.3 Global Gastrointestinal Drugs Sale Price by Players
3.4 Global Gastrointestinal Drugs Manufacturing Base Distribution, Sales Area, Product Types by Players
  3.4.1 Global Gastrointestinal Drugs Manufacturing Base Distribution and Sales Area by Players
  3.4.2 Players Gastrointestinal Drugs Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 GASTROINTESTINAL DRUGS BY REGIONS

4.1 Gastrointestinal Drugs by Regions
  4.1.1 Global Gastrointestinal Drugs Consumption by Regions
  4.1.2 Global Gastrointestinal Drugs Value by Regions
4.2 Americas Gastrointestinal Drugs Consumption Growth
4.3 APAC Gastrointestinal Drugs Consumption Growth
4.4 Europe Gastrointestinal Drugs Consumption Growth
4.5 Middle East & Africa Gastrointestinal Drugs Consumption Growth

5 AMERICAS

5.1 Americas Gastrointestinal Drugs Consumption by Countries
  5.1.1 Americas Gastrointestinal Drugs Consumption by Countries (2013-2018)
  5.1.2 Americas Gastrointestinal Drugs Value by Countries (2013-2018)
5.2 Americas Gastrointestinal Drugs Consumption by Type
5.3 Americas Gastrointestinal Drugs Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Gastrointestinal Drugs Consumption by Countries
  6.1.1 APAC Gastrointestinal Drugs Consumption by Countries (2013-2018)
  6.1.2 APAC Gastrointestinal Drugs Value by Countries (2013-2018)
6.2 APAC Gastrointestinal Drugs Consumption by Type
6.3 APAC Gastrointestinal Drugs Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 EUROPE

7.1 Europe Gastrointestinal Drugs by Countries
  7.1.1 Europe Gastrointestinal Drugs Consumption by Countries (2013-2018)
  7.1.2 Europe Gastrointestinal Drugs Value by Countries (2013-2018)
7.2 Europe Gastrointestinal Drugs Consumption by Type
7.3 Europe Gastrointestinal Drugs Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Gastrointestinal Drugs by Countries
  8.1.1 Middle East & Africa Gastrointestinal Drugs Consumption by Countries (2013-2018)
  8.1.2 Middle East & Africa Gastrointestinal Drugs Value by Countries (2013-2018)
8.2 Middle East & Africa Gastrointestinal Drugs Consumption by Type
8.3 Middle East & Africa Gastrointestinal Drugs Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers and Impact
  9.1.1 Growing Demand from Key Regions
  9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 MARKETING, DISTRIBUTORS AND CUSTOMER

10.1 Sales Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
10.2 Gastrointestinal Drugs Distributors
10.3 Gastrointestinal Drugs Customer

11 GLOBAL GASTROINTESTINAL DRUGS MARKET FORECAST

11.1 Global Gastrointestinal Drugs Consumption Forecast (2018-2023)
11.2 Global Gastrointestinal Drugs Forecast by Regions
  11.2.1 Global Gastrointestinal Drugs Forecast by Regions (2018-2023)
  11.2.2 Global Gastrointestinal Drugs Value Forecast by Regions (2018-2023)
  11.2.3 Americas Consumption Forecast
  11.2.4 APAC Consumption Forecast
  11.2.5 Europe Consumption Forecast
  11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
  11.3.1 United States Market Forecast
  11.3.2 Canada Market Forecast
  11.3.3 Mexico Market Forecast
  11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
  11.4.1 China Market Forecast
  11.4.2 Japan Market Forecast
  11.4.3 Korea Market Forecast
  11.4.4 Southeast Asia Market Forecast
  11.4.5 India Market Forecast
  11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
  11.5.1 Germany Market Forecast
  11.5.2 France Market Forecast
  11.5.3 UK Market Forecast
  11.5.4 Italy Market Forecast
  11.5.5 Russia Market Forecast
  11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
  11.6.1 Egypt Market Forecast
  11.6.2 South Africa Market Forecast
  11.6.3 Israel Market Forecast
  11.6.4 Turkey Market Forecast
  11.6.5 GCC Countries Market Forecast
11.7 Global Gastrointestinal Drugs Forecast by Type
11.8 Global Gastrointestinal Drugs Forecast by Application

12 KEY PLAYERS ANALYSIS

12.1 AstraZeneca
  12.1.1 Company Details
  12.1.2 Gastrointestinal Drugs Product Offered
  12.1.3 AstraZeneca Gastrointestinal Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
  12.1.4 Main Business Overview
  12.1.5 AstraZeneca News
12.2 Sanofi
  12.2.1 Company Details
  12.2.2 Gastrointestinal Drugs Product Offered
  12.2.3 Sanofi Gastrointestinal Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
  12.2.4 Main Business Overview
  12.2.5 Sanofi News
12.3 Bayer
  12.3.1 Company Details
  12.3.2 Gastrointestinal Drugs Product Offered
  12.3.3 Bayer Gastrointestinal Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
  12.3.4 Main Business Overview
  12.3.5 Bayer News
12.4 Pfizer
  12.4.1 Company Details
  12.4.2 Gastrointestinal Drugs Product Offered
  12.4.3 Pfizer Gastrointestinal Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
  12.4.4 Main Business Overview
  12.4.5 Pfizer News
12.5 GlaxoSmithKline
  12.5.1 Company Details
  12.5.2 Gastrointestinal Drugs Product Offered
  12.5.3 GlaxoSmithKline Gastrointestinal Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
  12.5.4 Main Business Overview
  12.5.5 GlaxoSmithKline News
12.6 Teva
  12.6.1 Company Details
  12.6.2 Gastrointestinal Drugs Product Offered
  12.6.3 Teva Gastrointestinal Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
  12.6.4 Main Business Overview
  12.6.5 Teva News
12.7 Zeria(Tillotts)
  12.7.1 Company Details
  12.7.2 Gastrointestinal Drugs Product Offered
  12.7.3 Zeria(Tillotts) Gastrointestinal Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
  12.7.4 Main Business Overview
  12.7.5 Zeria(Tillotts) News
12.8 Perrigo
  12.8.1 Company Details
  12.8.2 Gastrointestinal Drugs Product Offered
  12.8.3 Perrigo Gastrointestinal Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
  12.8.4 Main Business Overview
  12.8.5 Perrigo News
12.9 Boehringer Ingelheim
  12.9.1 Company Details
  12.9.2 Gastrointestinal Drugs Product Offered
  12.9.3 Boehringer Ingelheim Gastrointestinal Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
  12.9.4 Main Business Overview
  12.9.5 Boehringer Ingelheim News
12.10 Purdue Pharma
  12.10.1 Company Details
  12.10.2 Gastrointestinal Drugs Product Offered
  12.10.3 Purdue Pharma Gastrointestinal Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
  12.10.4 Main Business Overview
  12.10.5 Purdue Pharma News
12.11 C.B. Fleet
12.12 Abbott
12.13 Jiangzhong
12.14 Xian-Janssen

13 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Gastrointestinal Drugs
Table Product Specifications of Gastrointestinal Drugs
Figure Gastrointestinal Drugs Report Years Considered
Figure Market Research Methodology
Figure Gl